Sofinnova Ventures — 2017 Investments
2 investments dated 2017 · listed companies and verified rows first · show all
Apellis Pharmaceuticals, Inc.Aug 2017
Developing therapeutics for autoimmune and inflammatory diseases.
Crestwood, US
Board seatMaha Katabi· per SEC Form D
Entellus MedicalJul 2017
HealthtechPlymouth, US
John K. Bakewell(Director)Brian E. Farley(Director)Shawn T McCormick(Director)David B. Milne(Director)Douglas Rohlen(Director)Stephen R. Paidosh(Executive Officer)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.